Composition:
Palbociclib 75mg / 100mg / 125mg
Description:
Piclib is an advanced oncology therapy designed to slow the progression of HR-positive, HER2-negative metastatic breast cancer. It contains palbociclib, a CDK4/6 inhibitor that targets proteins responsible for cell division, effectively halting the proliferation of cancer cells. Used in combination with hormonal therapies, Piclib helps extend progression-free survival and provides a targeted treatment approach with manageable side effects.
It has become a critical component in breast cancer care, especially for patients seeking a well-tolerated oral option that works at the cellular level to delay disease advancement.
Share your experience with our medical product. Write a review!
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
14 Mar 2026
How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices
A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes
05 Feb 2026
Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally
Diet plays a crucial role in the development and management of type 2 diabetes.
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
